Business
Biofrontera : Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year 2025
Biofrontera : Corporate Governance Statement of Biofrontera AG pursuant to Sections 289f, 315d HGB for the financial year
About this update from Biofrontera Ag
[{"type":"text","content":"\n \n Declaration by Biofrontera AG on corporate governance pursuant to Sections 289f, 315d HGB for the 2024 financial year\n \n \n \n Dear ,\n \n \n \n Corporate governance refers to the legal and factual regulatory framework for the management and supervision of a company.\n \n \n \n As a listed company, the company is obliged to issue a corporate governance statement in accordance with Sections 289f and 315d of the German Commercial Code (HGB), including the Group.\n \n \n \n In accordance with Section 289f (1) HGB, the corporate governance statement must be included in the management report and forms a separate section there. It can also be made publicly available on the company's website. In this case, a reference to the website must be included the management report. The company has made use of this option, i.e. this corporate governance statement has not been included in the management report for the 2024 financial year, but only the website where the corporate governance statement is publicly accessible has been included there.\n \n \n Reproduction of the declaration of compliance in accordance with Sections 289 f (2) No. 1, 315d HGB\n \n \n \n The wording of the most recent declaration issued in April 2025 is published on the company's website at https://www.biofrontera.com/de/investoren/corporate-governance (\"Declaration of Conformity 2025\").\n \n \n \n The Management Board and Supervisory Board of Biofrontera AG declare the Declaration of Conformity 2025:\n \n \n \n \"Biofrontera AG has complied with the recommendations of the German Corporate Governance Code (the \"Code\") since the last declaration of conformity was issued in December 2023 (with supplement and re-publication in April 2024), with the following exceptions\n \n \n \n Code recommendations A.5 (description of the main features of the control and risk management system and statement on the appropriateness and effectiveness of these systems in the management report)\n \n \n The management report of Biofrontera AG complies with the legal requirements and describes the main features of the internal control system and the risk management system. However, it was decided not to comment on the appropriateness and effectiveness of these systems, as the Management Board and Supervisory Board have not identified any objections with regard to their appropriateness...